SG/PUT/AMGEN/300/0.1/20.09.24 | Delayed Deutsche Boerse AG 01:21:38 2024-07-11 pm EDT | ||
| 0.48 EUR | -17.24% |
|
| Current month | -28.40% | ||
| 1 month | -47.27% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 24-07-11 | 0.48 | -17.24% |
| 24-07-10 | 0.58 | -19.44% |
| 24-07-09 | 0.72 | -12.20% |
| 24-07-08 | 0.82 | 0.00% |
| 24-07-05 | 0.82 | -8.89% |
Delayed Quote Deutsche Boerse AG
Last update July 11, 2024 at 01:21 pm EDT
More quotesStatic data
| Product type | Warrant Plain-Vanilla |
|---|---|
| Buy / Sell | PUT |
| Underlying | AMGEN INC. |
| Issuer | 
Société Générale
|
| WKN | SW38XN |
| ISIN | DE000SW38XN6 |
| Date issued | 2023-10-03 |
| Strike | 300 $ |
| Maturity | 2024-09-20 (71 Days) |
| Parity | 10 : 1 |
| Emission price | 3.83 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 5.08 € |
|---|---|
| Lowest since issue | 0.46 € |
| Spread | 0.01 € |
| Spread % | 2.08% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
321.7
USD
Average target price
316.1
USD
Spread / Average Target
-1.72%
- Stock Market
- Warrants
- Warrant
